IFNB1 and neoplasm: Furthermore, IFN-β has shown anti-tumor potential, as demonstrated by its incorporation into a fusion construct with an anti-Her2 antibody (Lee et al., 2020), suggesting its broad applicability in new cytokine fusion formats for treating different diseases.